The Influence of advanced age on the treatment and prognosis of diffuse large-cell lymphoma (DLCL).
about
Rituximab plus gemcitabine: a therapeutic option for elderly or frail patients with aggressive non Hodgkin's lymphoma?Autologous stem cell transplantation beyond 60 years of age.Anthracyclines: a cornerstone in the management of non-Hodgkin's lymphomaOutcome of frail elderly patients with diffuse large B-cell lymphoma prospectively identified by Comprehensive Geriatric Assessment: results from a study of the Fondazione Italiana Linfomi.Toxicities and outcomes among septuagenarians and octogenarians with diffuse large B-cell lymphoma treated with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone therapy.
P2860
The Influence of advanced age on the treatment and prognosis of diffuse large-cell lymphoma (DLCL).
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
The Influence of advanced age ...... se large-cell lymphoma (DLCL).
@ast
The Influence of advanced age ...... se large-cell lymphoma (DLCL).
@en
The Influence of advanced age ...... of diffuse large-cell lymphoma
@nl
type
label
The Influence of advanced age ...... se large-cell lymphoma (DLCL).
@ast
The Influence of advanced age ...... se large-cell lymphoma (DLCL).
@en
The Influence of advanced age ...... of diffuse large-cell lymphoma
@nl
prefLabel
The Influence of advanced age ...... se large-cell lymphoma (DLCL).
@ast
The Influence of advanced age ...... se large-cell lymphoma (DLCL).
@en
The Influence of advanced age ...... of diffuse large-cell lymphoma
@nl
P2093
P356
P1476
The Influence of advanced age ...... se large-cell lymphoma (DLCL).
@en
P2093
P304
P356
10.3816/CLM.2001.N.002
P577
2001-03-01T00:00:00Z